In recent years, the landscape of HIV treatment has evolved significantly, leading to the development of various antiretroviral therapies. Among these, Biktarvy and Tivicay have emerged as two prominent options for managing the virus effectively. As individuals living with HIV seek to understand their treatment options, it is crucial to explore the distinctions, efficacy, and overall impact of these medications. Both Biktarvy and Tivicay are designed to help individuals maintain viral suppression and improve their quality of life. They belong to different classes of antiretroviral drugs, which means their mechanisms of action, dosing regimens, and potential side effects can vary significantly. Understanding these differences can empower patients and healthcare providers…